Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2005 May;179(3):673-7.
doi: 10.1007/s00213-004-2077-2. Epub 2004 Nov 18.

Loss of serotonin 5-HT2A receptors in the postmortem temporal cortex correlates with rate of cognitive decline in Alzheimer's disease

Affiliations
Comparative Study

Loss of serotonin 5-HT2A receptors in the postmortem temporal cortex correlates with rate of cognitive decline in Alzheimer's disease

M K Lai et al. Psychopharmacology (Berl). 2005 May.

Abstract

Rationale: Previous studies have demonstrated reductions of serotonin 5-HT 2A receptors in the neocortex of Alzheimer's disease (AD) patients. However, it is unclear whether such losses play a role in the cognitive decline of AD.

Objectives: To correlate neocortical 5-HT 2A receptor alterations with cognitive decline in AD.

Methods: Postmortem frontal and temporal cortical 5-HT 2A receptors were measured by [3H]ketanserin binding in aged controls as well as in a cohort of AD patients who had been longitudinally assessed for cognitive decline and behavioral symptoms.

Results: 5-HT 2A receptor densities in both regions were reduced in severely demented AD patients compared to age-matched controls. In the temporal cortex, this reduction also correlated with the rate of decline of Mini-Mental State Examination (MMSE) scores. The association between 5-HT 2A receptor loss and cognitive decline was independent of the effects of choline acetyltransferase (ChAT) activity and presence of behavioral symptoms.

Conclusions: Our data suggest that loss of neocortical 5-HT 2A receptors may predict for faster cognitive decline in AD, and point to serotomimetics as potentially useful adjuvants to cholinergic replacement therapies.

PubMed Disclaimer

References

    1. Neurochem Res. 1992 Sep;17(9):917-22 - PubMed
    1. Ann Med. 2000 Apr;32(3):210-21 - PubMed
    1. J Neurol Neurosurg Psychiatry. 2000 Aug;69(2):172-7 - PubMed
    1. J Pharmacol Methods. 1985 Nov;14(3):213-28 - PubMed
    1. Neuroreport. 2002 Jul 2;13(9):1175-8 - PubMed

Publication types

Substances

LinkOut - more resources